MIRA Pharmaceuticals, Inc. (MIRA)
NASDAQ: MIRA · Real-Time Price · USD
1.540
+0.070 (4.76%)
Aug 15, 2025, 9:58 AM - Market open

MIRA Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020
Period Ending
Aug '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Market Capitalization
281916---
Market Cap Growth
117.44%21.65%----
Enterprise Value
261510---
Last Close Price
1.471.141.05---
PB Ratio
19.108.583.55---
P/TBV Ratio
20.988.583.55---
Debt / Equity Ratio
--0.00-0.820.13-1.32
Quick Ratio
2.453.928.270.262.570.04
Current Ratio
2.793.998.710.362.660.04
Return on Equity (ROE)
-556.87%-238.90%-634.30%-847.77%-198.47%-
Return on Assets (ROA)
-253.31%-127.59%-184.05%-209.10%-79.65%-
Return on Capital (ROIC)
-352.78%-152.34%-249.33%-359.67%-104.42%-
Earnings Yield
-29.16%-41.59%-77.21%---
Buyback Yield / Dilution
-20.70%-10.91%20.73%-38.60%--
Updated May 14, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q